Cargando…

Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population

BACKGROUND: In recent years, evidence that aldosteronism is a risk factor for metabolic disorders has increased. This study was designed to investigate the role of nonalcoholic fatty liver disease (NAFLD) and hypokalemia in primary aldosteronism (PA). METHODS: A total of 222 patients diagnosed with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yi, Chen, Xueyang, Chen, Qiang, Yu, Chaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101285/ https://www.ncbi.nlm.nih.gov/pubmed/33967948 http://dx.doi.org/10.3389/fendo.2021.565714

Ejemplares similares

PSUN61 Primary Aldosteronism Presenting as Chronic Hypokalemia in a Normotensive Patient
por: Aziz, Mohammad, et al.
Publicado: (2022)

Masking by hypokalemia—primary aldosteronism with undetectable aldosterone
por: Boyle, Rebecca A, et al.
Publicado: (2020)

FRI124 Insights From The Incidence Of Primary Aldosteronism In Patients With Hypokalemia (IPAHK(+)) - Study
por: Gruber, Sven, et al.
Publicado: (2023)

Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism
por: Pan, Chien-Ting, et al.
Publicado: (2021)

Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology
por: Chen, Yi-Ju, et al.
Publicado: (2022)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Online prediction model for primary aldosteronism in patients with hypertension in Chinese population: A two-center retrospective study
por: Lin, Wenbin, et al.
Publicado: (2022)

Endotoxins and Non-Alcoholic Fatty Liver Disease
por: Kessoku, Takaomi, et al.
Publicado: (2021)

“Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
por: Guo, Kangxiao, et al.
Publicado: (2022)

SFI, a sex hormone binding globulin based nomogram for predicting non-alcoholic fatty liver disease in the Chinese population
por: Hua, Xiaomin, et al.
Publicado: (2023)

Free Triiodothyronine Is Associated With Hepatic Steatosis and Liver Stiffness in Euthyroid Chinese Adults With Non-Alcoholic Fatty Liver Disease
por: Guo, Wen, et al.
Publicado: (2021)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes
por: Chen, Congling, et al.
Publicado: (2023)

Exercise intervention improves mitochondrial quality in non-alcoholic fatty liver disease zebrafish
por: Zou, Yun-Yi, et al.
Publicado: (2023)

Editorial: Diagnosis and Treatment of Primary Aldosteronism: from Clinical Origin to Translational Research
por: Wu, Wan-Chen, et al.
Publicado: (2021)

Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease
por: Hendrikx, Tim, et al.
Publicado: (2020)

Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease
por: Maruszczak, Katharina, et al.
Publicado: (2022)

The Relationship Between Renal Stones and Primary Aldosteronism
por: Chang, Chun-Kai, et al.
Publicado: (2022)

Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism
por: El Ghorayeb, Nada, et al.
Publicado: (2016)

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
por: Chen, Yinshuang, et al.
Publicado: (2023)

Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine
por: Zhou, Zhijia, et al.
Publicado: (2022)

Hypokalemia-Induced Rhabdomyolysis by Primary Aldosteronism Coexistent With Sporadic Inclusion Body Myositis
por: Lee, Jong Ha, et al.
Publicado: (2015)

Recurrent Hypokalemia and Adrenal Steroids in Patients With APECED
por: Borchers, Joonatan, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Independent Risk Factor for Developing New-Onset Diabetes After Acute Pancreatitis: A Multicenter Retrospective Cohort Study in Chinese Population
por: Lv, Yingqi, et al.
Publicado: (2022)

The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
por: Grefhorst, Aldo, et al.
Publicado: (2021)

Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease
por: Jung, Inha, et al.
Publicado: (2021)

Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease
por: Cheng, Yiping, et al.
Publicado: (2023)

Rates of Primary Aldosteronism Screening Among High-Risk Populations
por: Grigoryan, Seda, et al.
Publicado: (2021)

Associations Between Metabolic Profiles and Target-Organ Damage in Chinese Individuals With Primary Aldosteronism
por: Zhang, Shao-Ling, et al.
Publicado: (2020)

Analysis of risk factors for non-alcoholic fatty liver disease in hospitalized children with obesity before the late puberty stage
por: Zhou, Lishan, et al.
Publicado: (2023)

Hypokalemia-Induced Rhabdomyolysis Caused by Adrenal Tumor-Related Primary Aldosteronism: A Report of 2 Cases
por: Chen, Chung-Tso, et al.
Publicado: (2021)

Triglyceride to high-density lipoprotein cholesterol ratio is an independent predictor of liver fibrosis among pediatrics non-alcoholic fatty liver disease
por: Ting, Yi-Wen, et al.
Publicado: (2022)

Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science
por: Zhang, Shuwei, et al.
Publicado: (2020)

Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology
por: Zhao, Jiahui, et al.
Publicado: (2023)

Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease
por: Wu, Weiti, et al.
Publicado: (2021)

The Potential of ACTH in the Genesis of Primary Aldosteronism
por: Funder, John W.
Publicado: (2016)

Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

Cardiovascular and metabolic characters of KCNJ5 somatic mutations in primary aldosteronism
por: Chang, Yi-Yao, et al.
Publicado: (2023)

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension
por: Bioletto, Fabio, et al.
Publicado: (2023)

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
por: Borges-Canha, Marta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c917on9q192f6rhp4hvnbvk87g